AU2003258598A1 - Substituted 1,2,3,4-tetrahydroquinoline derivatives - Google Patents
Substituted 1,2,3,4-tetrahydroquinoline derivativesInfo
- Publication number
- AU2003258598A1 AU2003258598A1 AU2003258598A AU2003258598A AU2003258598A1 AU 2003258598 A1 AU2003258598 A1 AU 2003258598A1 AU 2003258598 A AU2003258598 A AU 2003258598A AU 2003258598 A AU2003258598 A AU 2003258598A AU 2003258598 A1 AU2003258598 A1 AU 2003258598A1
- Authority
- AU
- Australia
- Prior art keywords
- substituted
- tetrahydroquinoline derivatives
- tetrahydroquinoline
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/06—Peri-condensed systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2002136910 DE10236910A1 (en) | 2002-08-12 | 2002-08-12 | Substituted 1,2,3,4-tetrahydroquinoline derivatives |
DE10236910.0 | 2002-08-12 | ||
PCT/EP2003/008889 WO2004022542A2 (en) | 2002-08-12 | 2003-08-11 | Substituted 1,2,3,4-tetrahydroquinoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003258598A1 true AU2003258598A1 (en) | 2004-03-29 |
Family
ID=31501737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003258598A Abandoned AU2003258598A1 (en) | 2002-08-12 | 2003-08-11 | Substituted 1,2,3,4-tetrahydroquinoline derivatives |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003258598A1 (en) |
DE (1) | DE10236910A1 (en) |
WO (1) | WO2004022542A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005063735A1 (en) * | 2003-12-20 | 2005-07-14 | Merck Patent Gmbh | 2-(hetero)-aryl-substituted tetrahydroquinoline derivatives |
DE102004020908A1 (en) * | 2004-04-28 | 2005-11-17 | Grünenthal GmbH | Substituted 5,6,7,8-tetrahydropyrido [4,3-d] pyrimidin-2-yl and 5,6,7,8-tetrahydroquinazolin-2-yl compounds |
DE102005027169A1 (en) * | 2005-06-13 | 2006-12-14 | Merck Patent Gmbh | tetrahydroquinoline |
US20080214537A1 (en) * | 2007-03-02 | 2008-09-04 | Cara Therapeutics, Inc. | Bridged phenanthridines |
US8546427B2 (en) * | 2010-10-20 | 2013-10-01 | Hoffmann-La Roche Inc. | Tetrahydroquinoline derivatives |
WO2014053315A1 (en) * | 2012-10-02 | 2014-04-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Tetrahydroquinoline derivatives and their use as epac inhibitors |
CN110372589B (en) * | 2019-08-13 | 2020-12-25 | 聊城大学 | Preparation method of 4- (4-tert-butylphenyl) -2-phenyl-1, 2,3, 4-tetrahydroquinoline-8-methyl formate |
TW202241852A (en) | 2020-12-25 | 2022-11-01 | 日商東麗股份有限公司 | Tetrahydroquinoline derivatives and medical use thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5017584A (en) * | 1984-12-20 | 1991-05-21 | Sterling Drug Inc. | Antidepressant 2-(4,5-dihydro-1H-imidazolyl)-dihydro-1H-indoles, -1,2,3,4-tetrahydroquinolines and -1H-indoles, and methods of use thereas |
DE4125270A1 (en) * | 1991-07-31 | 1993-02-04 | Bayer Ag | QUINOLINE-2-YL-METHOXYBENZYLHYDROXYHARNSTOFFE |
GB9216911D0 (en) * | 1992-08-10 | 1992-09-23 | Merck Sharp & Dohme | Therapeutic agents |
NZ319596A (en) * | 1995-09-29 | 1999-09-29 | Glaxo Wellcome Spa | 4-phenylcarbamoylmethylene-1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
AU5797098A (en) * | 1996-12-18 | 1998-07-15 | Eli Lilly And Company | Combinatorial process for preparing hydrofuroquinoline libraries |
WO1998034115A1 (en) * | 1997-02-04 | 1998-08-06 | Trega Biosciences, Inc. | 4-substituted-quinoline derivatives and 4-substitute-quinoline combinatorial libraries |
US5925527A (en) * | 1997-02-04 | 1999-07-20 | Trega Biosciences, Inc. | Tricyclic Tetrahydroquinoline derivatives and tricyclic tetrahydroquinoline combinatorial libraries |
DE10005302A1 (en) * | 2000-02-07 | 2002-01-17 | Gruenenthal Gmbh | Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
EP1425015A4 (en) * | 2001-08-20 | 2004-12-15 | Bristol Myers Squibb Co | Tetrahydroquinoline derivatives as antithrombotic agents |
-
2002
- 2002-08-12 DE DE2002136910 patent/DE10236910A1/en not_active Withdrawn
-
2003
- 2003-08-11 AU AU2003258598A patent/AU2003258598A1/en not_active Abandoned
- 2003-08-11 WO PCT/EP2003/008889 patent/WO2004022542A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004022542A2 (en) | 2004-03-18 |
WO2004022542A3 (en) | 2004-06-03 |
DE10236910A1 (en) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002361992A1 (en) | 1,4-dihydro-1,4-diphenylpyridine derivatives | |
AU2002341195A1 (en) | Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives | |
AP2004003166A0 (en) | Quinolinone derivatives. | |
AU2002349676A1 (en) | 4-oxoquinoline derivatives | |
AU2003301968A1 (en) | 4-aminomethyl-1-aryl-cyclohexylamine derivatives | |
AU2003264207A1 (en) | 1,4-substituted cyclohexane derivatives | |
AU2002347336A1 (en) | Quinoline derivatives | |
AU2003247706A1 (en) | 6, 11-4-carbon bridged erythromycin derivatives | |
AU2003287992A1 (en) | Cyclohexylurea derivatives | |
AU2001226794A1 (en) | Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives | |
AU2003300883A1 (en) | Substituted 1-benzoyl-3-cyano-pyrrolo(1,2-a)quinolines | |
AU2003278369A1 (en) | 3-cyano-quinoline derivatives | |
AU2003296564A1 (en) | 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives | |
AU2002347359A1 (en) | Quinoline derivatives | |
AU2003222659A1 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
AU2003269949A1 (en) | Substituted 1,4-pyrazine derivatives | |
AU2003234131A1 (en) | 5-o-mycaminosyltylonide derivatives | |
AU2003258598A1 (en) | Substituted 1,2,3,4-tetrahydroquinoline derivatives | |
AU2003274551A1 (en) | Quinoline derivatives | |
AU2002363600A1 (en) | Novel phenyl-propargylether derivatives | |
AU2002328894A1 (en) | Substituted 4-aminocyclohexanol derivatives | |
AU2003252333A1 (en) | Novel tetrahydroquinoline derivatives | |
AU2003273398A1 (en) | Aroyl-piperidine derivatives | |
AU2003238180A1 (en) | 2-naphtamide derivatives | |
AU2002249639A1 (en) | Pyranocoumarin derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |